Appleberry, Holly C.
Shin, Robert K.
Article History
Accepted: 13 June 2022
First Online: 7 July 2022
Declarations
:
: This review article does not contain any studies with human or animal subjects performed by any of the authors.
: Dr. Appleberry declares no conflicts of interest. Dr. Shin has accepted honoraria for consulting or speaking for the following companies: Alexion, Biogen, Bristol Myers Squibb, EMD Serono, Genentech, Horizon, Mallinckrodt, Novartis, and Sanofi Genzyme. Dr. Shin has received research support from Genentech.